COMMUNITY HEALTHCARE TRUST INC (CHCT)
Real Estate · healthcare real estate investment trust (REIT) · NYSE
A healthcare-focused REIT specializing in acquiring and managing off-market medical properties across the United States to generate stable rental income.
What COMMUNITY HEALTHCARE TRUST INC does
Community Healthcare Trust is a real estate investment trust that acquires and owns properties leased to hospitals, doctors, healthcare systems, and other service providers. Its portfolio primarily consists of medical office buildings, inpatient rehabilitation facilities, and behavioral health centers located across 36 states in the United States.
Recent developments
In August 2026, the company announced a 31% dividend reduction to reallocate capital toward growth initiatives, including acquisitions and portfolio reinvestments. The company is actively pursuing a $99 million acquisition pipeline and has launched a strategic plan targeting improved occupancy rates and asset recycling.
From COMMUNITY HEALTHCARE TRUST INC's filing of 2026-08-04.
Themes: healthcare real estate, medical office buildings, outpatient healthcare, behavioral health facilities, rehab facilities
Fundamentals
- Price$13.68 as of 2026-10-08 close
- Market cap$392M as of 2026-07-28 (share count; price 2026-10-08)
- 1-year return-1.7% 2025-10-08 close $13.92 → 2026-10-08 close $13.68
- P/E17.58 as of 2026-10-08
- Net margin+4.2% FY2025, SEC XBRL
- ROE+1.2% FY2025, SEC XBRL
- Debt / equity1.36 as of 2026-09-03
- Revenue growth (YoY)+5.7% as of 2026-09-03
- Revenue CAGR (3y)+7.5% SEC XBRL
- Beta0.37 as of 2026-09-03
- Last reported earnings2026-08-04 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +9.3%; at least 11 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How CHCT compares in its sector
- price-to-earnings ratiobottom 25% 120 covered Real Estate peers, as of 2026-10-08
- net profit marginmiddle range 154 covered Real Estate peers, as of 2026-09-03
- return on equitymiddle range 158 covered Real Estate peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 155 covered Real Estate peers
- indicated dividend yieldtop 10% 140 covered Real Estate peers, as of 2026-09-03
Position among covered Real Estate companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Dividend coverage (FY2025)
Exceeded at least one reported measure. In FY2025, CHCT's dividend exceeded at least one reported measure of what it earned or generated (earnings payout 1052%, operating-cash-flow payout 95%). A payout above 100% in one year is not necessarily unsustainable, but it is not fully covered by that measure.
- Earnings payout1052% dividends / net income
- Operating-cash-flow payout95% dividends / operating cash flow — capital spending was not reported, so this does not subtract it
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How COMMUNITY HEALTHCARE TRUST INC looks technically
COMMUNITY HEALTHCARE TRUST INC (CHCT) is trading 17.8% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 23 trading days ago — a "death cross", a bearish long-term signal. A strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 44, with sellers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 34, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bearish about 4 trading days ago (its momentum flipped negative). It made a new 20-day low about 4 trading days ago. It is 3.4% above its 52-week low (its lowest price of the past year).
Trend
8
| Distance from the 200-day | it is trading 17.8% below its 200-day average, the long-term trend line — a long-term downtrend | -17.8% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $14.93 | $14.93 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $16.64 | $16.64 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing low 20 calendar days ago — the swings before that are what the structure reading is measured on | 20 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that downward direction; the labelling fails if price closes above 14.3778. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible downward five-wave sequence, in wave 4 (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 23 trading days ago — a "death cross", a bearish long-term signal | 23 sessions |
| Trend strength (14-day ADX) | a strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 44, with sellers in control | 43.7 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 34, neither overbought (above 70) nor oversold (below 30) | 34.4 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($13.29 to $14.60) — its "stochastic" reading is 30 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 29.5 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 4 trading days ago (its momentum flipped negative) | 4 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $19.16 | $19.16 |
|---|---|---|
| From the 52-week high | it is 28.6% below its 52-week high (its highest price of the past year) | -28.6% |
| Above the 52-week low | it is 3.4% above its 52-week low (its lowest price of the past year) | +3.4% |
| Below the 52-week high | it is 28.6% below its highest point of the past year | 28.6% |
| Since a 20-day breakout | it made a new 20-day low about 4 trading days ago | 4 sessions |
| Since a 55-day breakout | it made a new 55-day low about 4 trading days ago | 4 sessions |
| All-time high | its highest closing price on record is $52.54 (set on 2021-04-26) | $52.54 |
| Given back of the 52-week move | over the past year its closes ranged ($13.31 to $19.02), and it has given back almost all of its rise from last year’s low — 94% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $15.31 to $15.49. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 93.5% |
| From the all-time high | it is 74.0% below its all-time high | -74.0% |
| Nearest price level | it is trading 3.3% below a resistance level at $14.14 — a price it turned at four times since 2025-08-11, most recently on 2026-09-18. Since 2024-10-08 it has 0 such levels below the current price and 11 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +3.3% |
| All-time low | its lowest closing price on record is $13.23 (set on 2025-10-13) | $13.23 |
| Above the all-time low | it is 3.4% above its all-time low | +3.4% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are wider than usual versus its own recent 6-month history (wider than about 74% of it) | 74th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.3047 between its high and its low — about 2.2% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.3047 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $13.40 and $14.99 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $13.40 – $14.19 – $14.99 |
| Typical daily range (% of price) | its price moves about 2.2% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.2% |
| Stretch from the 200-day average | it is trading 9.7 daily ranges below its 200-day average price (17.8% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 9.7 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.04× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
3
| Since a hammer | 5 sessions ago, after a stretch of decline, it sold off hard during the session and then closed back near its high — a "hammer", the long lower wick showing the drop was bought back before the close | 5 sessions ago |
|---|---|---|
| Since a bullish engulfing | today it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | today |
| Since a bearish engulfing | 6 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 6 sessions ago |
Price gaps
3
| Gap at the open | it opened on 2026-10-08 at essentially the same price it closed at the session before — no meaningful overnight gap | 0.0% |
|---|---|---|
| Open gap | it gapped 6.0% below the previous close 45 sessions ago and has not traded back through the level it left behind at 17.71 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | -6.0% |
| Gap filled | a 2.5% gap down opened on 2026-08-19 has been "filled" 35 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 35 sessions ago |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 8.5 percentage points (the stock lost 7.4% while the market gained 1.0%) | -8.5% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 27.4 percentage points (the stock lost 23.5% while the market gained 3.8%) | -27.4% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 32.2 percentage points (the stock lost 14.7% while the market gained 17.5%) | -32.2% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 16.7 percentage points (the stock lost 1.7% while the market gained 15.0%) | -16.7% |
Signal agreement
2
| Bullish technical signals | 0 of the 9 technical signals we can compute for it are currently in a bullish state — these describe past price behaviour, not a forecast | 0 of 9 |
|---|---|---|
| Bearish technical signals | 6 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, MACD momentum is negative, a strong downtrend, with sellers in control, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 6 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 14% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 6.8% of the share price. | -13.6% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 16% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $16.23 — a volume-weighted average of daily closes over 191 sessions, not a true tick-by-tick VWAP. | -15.7% |
|---|---|---|
| Vs the average paid since it last reported | the price is 15% below the average price paid since it last reported on 2025-10-28 (its 10-Q), so the typical buyer over that stretch is under water. That average is $16.03 — a volume-weighted average of daily closes over 236 sessions, not a true tick-by-tick VWAP. | -14.7% |
Price levels it has turned at before
CHCT last closed at $13.68 on 2026-10-08. Since 2024-10-08 it has turned at 0 prices below its last close and 11 above; the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $14.14 | Resistance | 3.3% above the last close | turned there four times · 2025-08-11 to 2026-09-18 |
| $14.92 | Resistance | 9.1% above the last close | turned there four times · 2025-04-11 to 2025-12-11 |
| $15.38 | Resistance | 12.5% above the last close | turned there five times · 2025-10-01 to 2026-08-25 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes above $14.38.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
On past moves of this shape the leg has usually ended somewhere between $14.37 and $14.38 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
This reading has stood for 7 trading days, since 2026-09-30.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Recent death cross (50-day crossed below 200-day) · Pulled back from the 12-month high · MACD just crossed bearish (12/26/9) · Near the all-time low · lagging the market | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (2.25 mean, 1=Strong Buy…5=Strong Sell) — 4 analysts
- Mean price target$17.50 range $17.00 – $18.00
Analyst estimates, as of 2026-10-07. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Key risks (from latest filing)
["High geographic concentration in Texas and Florida makes the company vulnerable to regional economic downturns or regulatory changes.","The company's ability to maintain occupancy and rental rates depends on the financial stability of its healthcare tenants, over which it has no control.","Inflationary pressures and interest rate fluctuations can increase borrowing costs and impact property valuations."]
What changed in the latest 10-Q
AI-assisted comparison of CHCT's 10-Q filed 2026-08-04 against the prior one filed 2026-05-05.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-08-04) adds a second-quarter 2026 asset disposition disclosure: a property sold with net proceeds of approximately $0.4 million and a $46,000 gain on sale.
- Newer filing (2026-08-04) adds that the net proceeds from asset dispositions were used to repay outstanding balances on the Revolving Credit Facility.
- Newer filing (2026-08-04) adds lease activity for the first six months of 2026: expiring or terminated leases related to approximately 388,000 square feet and leased or renewed leases relating to approximately 342,000 square feet.
- Removed:
- Older filing (2026-05-05) describes the first-quarter 2026 disposed property as located in Florida, classified as an asset held for sale, and recognized an immaterial loss; the newer filing removes the Florida location and asset held for sale classification but retains the $5.2 million proceeds and loss amount.
- Older filing (2026-05-05) states the four acquisition pipeline properties are anticipated to close throughout 2026 and 2027; the newer filing replaces this with specific timing (one in third quarter 2026, one in fourth quarter 2026, remaining two in 2027).
- Older filing (2026-05-05) describes the purchase options as exercisable at March 31, 2026; the newer filing describes them as outstanding at June 30, 2026.
- Reworded:
- Newer filing (2026-08-04) changes the acquired facility square footage from approximately 37,000 square feet to approximately 37,151 square feet.
- Older filing (2026-05-05) says the Company has not entered into new interest rate swaps to fix the interest rate and it will be under a floating rate; newer filing (2026-08-04) says the Company has not replaced these interest rate swaps, so interest on the $75.0 million is now under the Revolving Credit Facility floating rate.
- Newer filing (2026-08-04) updates portfolio leased status date from March 31, 2026 to June 30, 2026 and lease activity period from first three months to first six months of 2026.
- Newer filing (2026-08-04) updates purchase option aggregate gross investment from approximately $42.0 million in 13 properties to approximately $38.2 million in 11 properties.
- Older filing (2026-05-05) includes a reference to Note 5 and Note 6 in the Interest Expense section for details on debt and interest rate swaps; the newer filing omits this cross-reference.
- Notes:
- Only the provided excerpt of the MD&A section was compared; the older filing text appears truncated at the Inflation section and the newer filing excerpt may also be incomplete.
Risk Factors
- Added:
- The newer filing (filed 2026-08-04) added rows for April, May, and June 2026 to the table under 'ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS' showing 5,621 shares purchased in June at an average price of $17.83, with 0 shares for April and May.
- The newer filing (filed 2026-08-04) added the total '5,621' at the bottom of the table under Item 2.
- The newer filing (filed 2026-08-04) added the date 'August 4, 2026' in the signatures section.
- Removed:
- The older filing (filed 2026-05-05) contained rows for January, February, and March 2026 in the table under 'ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS' showing 17,830 shares purchased in January at an average price of $16.70, with 0 shares for February and March, which are absent in the newer filing.
- The older filing (filed 2026-05-05) contained the total '17,830' at the bottom of the table under Item 2, which is absent in the newer filing.
- The older filing (filed 2026-05-05) contained Exhibit 10.1 'Community Healthcare Trust Incorporated Fourth Amended And Restated Alignment Of Interest Program Amendment No. 2 (3)' in the Exhibit Index, which is absent in the newer filing.
- The older filing (filed 2026-05-05) contained footnote (3) 'Filed as Exhibit 10.1 to the Form 8-K of the Company filed with the Securities and Exchange Commission on January 9, 2026 (File No. 001-37401) and incorporated herein by reference.', which is absent in the newer filing.
- The older filing (filed 2026-05-05) contained the date 'May 5, 2026' in the signatures section, which is absent in the newer filing.
- Reworded:
- The period reference in 'ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS' changed from 'During the three months ended March 31, 2026' in the older filing (filed 2026-05-05) to 'During the three months ended June 30, 2026' in the newer filing (filed 2026-08-04).
- The quarter reference in 'ITEM 5. OTHER INFORMATION, Rule 10b5-1' changed from 'During the quarter ended March 31, 2026' in the older filing (filed 2026-05-05) to 'During the quarter ended June 30, 2026' in the newer filing (filed 2026-08-04).
- Notes:
- The comparison included the full Part II sections provided in the source texts; the 'Risk Factors' sections themselves were identical between the two filings.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
2 open-market purchases and 0 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 90 days · read to 2026-10-042 buys ($272980) · 0 sells — 2 buying insiders
- Last 180 days · read to 2026-10-042 buys ($272980) · 0 sells — 2 buying insiders
Activity heuristic: net buying (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-14. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about CHCT's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Short interest (FINRA)
CHCT had 935,745 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
CHCT had 3.27% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 3.45 days to cover at the same settlement.
- Reported short interest (shares) 935,745
- Short interest (% of shares outstanding) 3.27%
- Prior settlement (shares) 1,103,454
- Reported change -15.2%
- Days to cover (reported) 3.45
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Healthcare Realty Trust (HR)
- Medical Properties Trust
- Physicians Realty Trust (DOC)
- Global Medical REIT (GMRE)
- Sabra Health Care REIT (SBRA)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare CHCT vs…
COMMUNITY HEALTHCARE TRUST INC is found in…
Frequently asked questions
What does COMMUNITY HEALTHCARE TRUST INC (CHCT) do?
Community Healthcare Trust is a real estate investment trust that acquires and owns properties leased to hospitals, doctors, healthcare systems, and other service providers. Its portfolio primarily consists of medical office buildings, inpatient rehabilitation facilities, and behavioral health centers located across 36 states in the United States.
What sector is COMMUNITY HEALTHCARE TRUST INC (CHCT) in?
COMMUNITY HEALTHCARE TRUST INC (CHCT) is classified in the Real Estate sector. Its industry is healthcare real estate investment trust (REIT). It trades on NYSE.
Does CHCT pay a dividend?
Yes — COMMUNITY HEALTHCARE TRUST INC (CHCT) pays a dividend, with an indicated yield of about 9.32% and at least 11 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-09-03). Informational only — not financial advice.
Who are COMMUNITY HEALTHCARE TRUST INC's (CHCT) competitors?
Notable peers of COMMUNITY HEALTHCARE TRUST INC (CHCT) include Healthcare Realty Trust, Medical Properties Trust, Physicians Realty Trust, Global Medical REIT and Sabra Health Care REIT. This peer set is informational only — not financial advice.
Is COMMUNITY HEALTHCARE TRUST INC (CHCT) overbought or oversold right now?
COMMUNITY HEALTHCARE TRUST INC (CHCT) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 34, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on CHCT come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.